18F-Labeled Choline Purification via Solid Phase Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing synthesis methods for 18F-labeled choline analogues, particularly those using non-gaseous paths, require High Performance Liquid Chromatography (HPLC) purification due to impurities, which is time-consuming and not suitable for automation, especially in single-use cassette-based systems, and poses risks from handling radioactive compounds.
Innovation Solution
A method involving a one-pot synthesis using an alkylating agent with a tosylate leaving group, followed by purification on a cation exchange cartridge and subsequent solid phase extraction (SPE) using a non-ionic solid support, such as Phenomenex Strata-X™, which retains impurities and reagents while allowing the 18F-labeled choline analogue to be eluted, eliminating the need for HPLC purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If HPLC purification is used to remove impurities from 18F-labeled choline analogues, then radiochemical purity is improved, but preparation time increases and automation becomes difficult
Solution Approach 1:
The patent extracts and removes specific impurities (arsenic, bromide, tosylate) using targeted purification methods: activated carbon for arsenic removal, ion exchange for bromide removal, and hydrolysis for tosylate removal. This selective extraction achieves high radiochemical purity without requiring time-consuming HPLC purification.
Solution Approach 2:
The patent employs disposable single-use cassettes and cartridges for the purification process, which can be discarded after a single use. This eliminates the need for complex cleaning and validation procedures associated with reusable HPLC systems, reducing preparation time and enabling easier automation while maintaining high purification effectiveness.
2Manufacturing precision
If HPLC purification is used to remove impurities, then radiochemical purity is improved, but the process becomes complex and difficult to automate
Solution Approach 1:
The patent segments the purification process into three independent, simplified steps: activated carbon filtration for arsenic removal, ion exchange for bromide removal, and hydrolysis for tosylate removal. Each step targets a specific impurity type and can be performed independently using simple, automated-compatible equipment, avoiding the complexity of HPLC systems.
Solution Approach 2:
The patent introduces intermediate purification steps using activated carbon and ion exchange resins as mediators between the synthesis reaction and final product formulation. These intermediaries selectively bind and remove specific impurities, simplifying the overall purification process and making it compatible with automated single-use cassette systems.
3Productivity
If standard synthesis methods with gaseous intermediates are used, then radiochemical yield is improved, but handling safety risks increase
Solution Approach 1:
The patent changes the physical state parameter of the alkylating agent from gaseous to solid form by using tosylate salts instead of gaseous reagents. This parameter change eliminates the need for gas handling equipment and associated safety risks, while the solid reagents can be easily handled in automated single-use cassette systems with comparable or improved radiochemical yields.
4Object-affected harmful factors
If non-gaseous synthesis paths are used to avoid radioactive gas handling, then safety is improved, but HPLC purification becomes necessary due to impurities
Solution Approach 1:
The patent converts the potential harm of using non-gaseous synthesis paths (which produce different types of impurities) into a benefit by developing targeted removal methods for these specific impurities. The solid-phase synthesis produces arsenic, bromide, and tosylate impurities that can be selectively removed using simple, rapid methods, ultimately achieving faster overall purification compared to HPLC despite the alternative synthesis route.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach simplifies the automation of 18F-labeled choline analogue synthesis, reduces preparation time, increases yield, and ensures high radiochemical purity by effectively removing impurities, making the process more reliable and efficient.
Implementation Method 1
purification of a crude solution of synthesized 18F-fluoromethylcholine on a cation exchange cartridge on which the 18F-fluoromethylcholine is trapped
Implementation Method 2
purification of said eluted 18F-fluoromethylcholine bulk product by solid phase extraction (SPE) using a non-ionic solid support for retaining impurities and reagents from the eluted solution
Data Source
Figure 1~2
AI summary
The present invention relates to a method for the purification of 18F-labeled choline analogues in a solution injectable to a patient, prepared using non-gaseous synthesis paths, comprising a step of solid phase extraction (SPE) purification using a solid support, wherein the solid support used in the solid phase extraction purification has the characteristic to retain impurities and reagents from the solution but not the 18F-labeled choline analogues